Thymidylate synthase levels as a therapeutic and prognostic predictor in breast cancer

Anticancer Research

Volumn 19, Issue 6 C, 1999, Pages 5621-5626

  Nishimura, Reiki ^a   Nagao, K ^a   Miyayama, H ^a   Matsuda, M ^a   Baba, K ^a   Matsuoka, Y ^a   Yamashita, H ^a   Fukuda, M ^a   Higuchi, A ^a   Satoh, A ^a   Mizumoto, T ^a   Hamamoto, R ^a  

^a KUMAMOTO CITY HOSPITAL   (Japan)

Author keywords

5 FU; Breast cancer; Prognosis; Proliferative activity; Thymidylate synthase

Indexed keywords

DNA DIRECTED DNA POLYMERASE ALPHA; EPIRUBICIN; FLUOROURACIL; THYMIDYLATE SYNTHASE; UFT;

ARTICLE; BREAST CANCER; BREAST DISEASE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL FEATURE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; THYMIDYLATE SYNTHASE;

EID: 19244381642     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Danenberg PV: Thymidylate synthase: A target enzyme in cancer chemotherapy. Biochim Biophys Acta 473: 73-92, 1977.
2. Santi DV, McHenry CS, Sommer M: Mechanisms of interaction of thymidylate synthase with 5-fluorodeoxyuridylate. Biochemistry 13: 471-480, 1974.
3. Santi DV, Danenberg PV: Mechanisms of interaction of thymidylate synthase with 5-fluorodeoxyuridylate folates in pyrimidine nucleocide biosynthesis, in Blakely RL, Benkovic SJ (eds): Folates and Pterins. New York, NY, Wiley, 1984, pp 385-398.
4. Spears CP, Shahinian AH, Moran RG, Heidelberger C, Corbett TH: In vivo kinetics of thymidylate synthase inhibition in 5-fluorouracil- sensitive and - resistant murine colon adenocancers. Cancer Res 42: 450-456, 1982.
5. Shutte B, Reynders MM, Bosman FT, Blijham GH: Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin- embedded tissue. Cytometry 6: 2625-2630, 1985.
6. Dean PN, Jett JH: Mathematical analysis of DNA distribution derived from flow microfluorometry. J Cell Biol 60: 523, 1974.
7. Nishimura R, Nagao K, Miyayama H, Matsuda M, Baba K, Matsuoka Y, Ueno Y, Yamashita H, Higuchi A, Suzuki S, Ishihara A: Prognostic significance and application to adjuvant therapy of flow cytometric DNA analysis in breast cancer. Jpn J Breast Cancer 9: 287- 292, 1994.
8. Nishimura R, Nagao K, Miyayama H, Ishihara A, Matsuda M, Baba K, Matsuoka Y, Yamashita H, Fukuda M, Higuchi A, Saiki T: Evaluation of DNA polymerase as a prognostic predictor in early breast cancer smaller than 2 cm. Breast Cancer 2: 45-50, 1995.
9. Yamamoto N, Miyauchi M, Fujita Y, Nakajima N: Thymidylate synthase levels after preoperative oral administration of 5-fluorouracil for breast cancer patients - comparison with histological effect and DNA histogram -. J Jpn Soc Cancer Ther 31: 1106-1112, 1996.
10. Komaki K, Kamamura Y, Ohmine Y, Sasa M, Tanaka K, Inoue H, Uyama T, Morimoto T, Monden Y: Difference in thymidylate synthase activity in involved nodes compared with primary tumor in breast cancer patients. Breast Cancer Res Treat 35: 157-162, 1995.
11. Pestalozzi BC, Peterson RD, Gelger A, Goldhirsch A, Guslerson BA, Trihia H, Lindtner J, Corlés-Funes H, Simmoncini E, Byrne MJ, Golouh R, Rudenslam CM, Castiglione-Gerlsch M, Allegra CJ, Johnston PG: Prognostic importance of thymidylate synthase expression in early breast cancer. J Clin Oncol 15: 1923-1931, 1997.
12. Mitamura T, Sakamoto S, Kudo H, Suzuki S, Maemura M, Nakayama T: Clinicopathological stages and mammary DNA synthesizing enzyme activity in patients with mammary cancer. Medicine and Biology 133: 61-64, 1996.
13. Larsson PA, Carlsson G, Gustavsson B, Spears CP: Thymidylate synthase in advanced gastointestinal and breast cancers. Acta Oncologica 35: 469-472, 1996.
14. Ebuchi M, Sakamoto S, Kudo H, Nagase J, Endo M: Clinicopathological stages and pyrimidine nucleotide synthesis in human mammary cancers. Anticancer Res 15: 1481-1484, 1995
15. Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, Chabner BA, Allegra CJ: The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol 12: 2640-2647, 1994.
16. Johnston PG, Lenz HJ, Leichman CG, Dannenberg KD, Allegra CJ, Dannenberg PV, Leichman L: Thymidylate synthase Gene and protein expression correlate and are associated with response to 5- fluorouracil in human colorectal and gastric tumors. Cancer Res 55: 1407-1412, 1995.
17. Lenz HJ, Leichman CG, Danenberg KD, Danenberg PV, Grashen S, Cohen H, Laine L, Crookes P, Silberman H, Baranda J, Garcia Y, Li J, Leichman L: Thymidylate synthase mRNA level in adenocancer of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol 14: 176-182, 1995.
18. Johnston PG, Mick R, Recant W, Behan KA., Dolan ME, Ratain MJ, Beckmann E, Weichselbaum RR, Allegra CJ, Volkes EE: Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer. J Natl Cancer Inst 89: 308-313, 1997.